5:44 PM
 | 
Jun 12, 2013
 |  BC Extra  |  Financial News

Celgene announces $3 billion repurchase program

Celgene Corp. (NASDAQ:CELG) said its board authorized the repurchase of up to $3 billion in...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >